|
Market Closed -
Bombay S.E.
03:32:33 23/10/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 2,404.80 INR | -1.23% |
|
-6.25% | -2.68% |
| 03/08 | GSK India first-quarter profit rises on steady vaccine demand | RE |
| 03/08 | GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
| Market Cap | 41TCr 429.15Cr 383.23Cr 354.03Cr 320.83Cr 600.23Cr 610.16Cr 4.26TCr 1.69TCr 21TCr 1.61TCr 1.58TCr 67TCr | P/E 2027 * |
35x | P/E 2028 * | 30.4x |
|---|---|---|---|---|---|
| Enterprise Value | 41TCr 429.15Cr 383.23Cr 354.03Cr 320.83Cr 600.23Cr 610.16Cr 4.26TCr 1.69TCr 21TCr 1.61TCr 1.58TCr 67TCr | EV / Sales 2027 * |
9.57x | EV / Sales 2028 * | 8.62x |
| Free-Float |
24.37% | Yield 2027 * |
1.23% | Yield 2028 * | 1.23% |
| Markets | Quality | ||
|---|---|---|---|
Bombay S.E.
| GLAXO | Delayed | |
NSE India S.E.
| GLAXO | Delayed |
Last Transcript: GlaxoSmithKline Pharmaceuticals Limited
| 1 day | -1.23% | ||
| 1 week | -6.25% | ||
| Current month | -13.11% | ||
| 1 month | -16.40% | ||
| 3 months | -3.58% | ||
| 6 months | -3.48% | ||
| Current year | -2.68% |
| 1 week | 2,342.7 |  | 2,575 |
| 1 month | 2,342.7 | | 2,986.65 |
| Current year | 2,088 | | 3,121.1 |
| 1 year | 2,088 | | 3,121.1 |
| 3 years | 1,387.9 | | 3,515.95 |
| 5 years | 1,228 | | 3,515.95 |
| 10 years | 1,020 | | 3,515.95 |
| Manager | Title | Age | Since |
|---|---|---|---|
Bhushan Akshikar
CEO | Chief Executive Officer | 56 | 01/12/2022 |
Ronojit Biswas
DFI | Director of Finance/CFO | - | 01/04/2026 |
| Chief Tech/Sci/R&D Officer | - | 26/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Renu Sud Karnad
CHM | Chairman | 73 | 01/04/2019 |
| Director/Board Member | 59 | 18/05/2020 | |
Manu Anand
BRD | Director/Board Member | 67 | 16/05/2022 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.23% | -6.25% | -12.86% | +64.26% | 429.15Cr | |
| -2.54% | +1.31% | +55.10% | +120.84% | 1,13500Cr | |
| -1.42% | +3.23% | +37.07% | +74.26% | 64TCr | |
| +0.16% | +0.08% | +25.14% | +97.36% | 50TCr | |
| -0.31% | +3.09% | +43.92% | +64.55% | 38TCr | |
| -1.34% | -0.47% | +66.63% | +40.56% | 36TCr | |
| -0.68% | +2.65% | +22.46% | +51.48% | 29TCr | |
| -1.20% | +3.04% | +2.62% | +26.97% | 27TCr | |
| -1.79% | +1.57% | +49.97% | +60.87% | 24TCr | |
| -0.73% | -0.10% | +29.24% | +101.19% | 19TCr | |
| Average | -0.72% | +1.33% | +31.93% | +70.23% | 40.09TCr | |
| Weighted average by Cap. | -0.26% | +2.65% | +40.94% | +82.11% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 4.26TCr 45Cr 40Cr 37Cr 34Cr 63Cr 64Cr 445.16Cr 176.24Cr 2.23TCr 168.29Cr 164.71Cr 7.03TCr | 4.72TCr 50Cr 44Cr 41Cr 37Cr 70Cr 71Cr 494.03Cr 195.59Cr 2.48TCr 186.76Cr 182.79Cr 7.8TCr |
| Net income | 1.17TCr 12Cr 11Cr 10Cr 9.18Cr 17Cr 17Cr 121.88Cr 48Cr 610.61Cr 46Cr 45Cr 1.93TCr | 1.34TCr 14Cr 13Cr 12Cr 11Cr 20Cr 20Cr 140.32Cr 56Cr 703.02Cr 53Cr 52Cr 2.22TCr |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/26/23 | ₹2,404.80 | -1.23% | 3,432 |
| 22/26/22 | ₹2,434.70 | -1.18% | 1,430 |
| 21/26/21 | ₹2,463.75 | -1.04% | 2,472 |
| 19/26/19 | ₹2,489.70 | -2.94% | 1,124 |
| 16/26/16 | ₹2,565.20 | +1.67% | 2,374 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GLAXO Stock
Select your edition
All financial news and data tailored to specific country editions
